Clinical Trials

Clinical Research Trials Search Results

Page of 3, showing items 1-10 of 26.
  • ALCHEMIST Trials (Alliance A151216, A081801 & ECOG E4512)

    The ALCHEMIST trials are testing therapies that target two types of genetic changes that are thought to drive lung cancer growth: mutations in the EGFR gene and a rearrangement of the ALK gene.

  • AFT-25/COMET

    This study looks at the risks and benefits of active surveillance (AS) compared to guideline concordant care (GCC) in the setting of a pragmatic prospective randomized trial for low risk DCIS.

  • AFT-19

    A study in men with biochemically recurrent prostate cancer and PSA doubling time = 9 months at the time of study entry.

  • ECOG-ACRIN EAY131/MATCH

    This precision medicine cancer treatment trial seeks to determine whether treating cancer based on specific genetic changes is effective.

  • SWOG S1802

    This phase III trial studies how well standard systemic therapy with or without definitive treatment works in treating participants with prostate cancer that has spread.

  • Alliance A031704 “PDIGREE”

    A phase III trial in metastatic untreated renal cell cancer.

  • EA5163 INSIGNA

    This phase III trial studies whether pembrolizumab alone as a first-line treatment, followed by pemetrexed and carboplatin with or without pembrolizumab after disease progression is superior to induction with pembrolizumab, pemetrexed and carboplatin followed by pembrolizumab and pemetrexed maintenance in treating patients with stage IV non-squamous non-small cell lung cancer.

  • LUNGMAP: Including SWOG S1900E

    This screening and multi-sub-study randomized phase II/III trial will establish a method for genomic screening of similar large cancer populations followed by assigning and accruing simultaneously to a multi-sub-study hybrid Master Protocol (LUNGMAP).

  • NRG BR004

    This randomized phase III trial studies how well paclitaxel, trastuzumab, and pertuzumab with or without atezolizumab works in treating patients with breast cancer that has spread to other parts of the body.

  • CCTG MA39 TAILOR RT

    The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy.

Page of 3, showing items 1-10 of 26.